Clinical Trials

Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 281 - 300 of 446 trials
Titlesort icon Investigator Disease(s)
A Phase III Study of Doxorubicin Alone or in Combination with TH-302 in Patients with Locally Advanced Inoperable or Metastatic Soft-Tissue Sarcoma
[Protocol 11-203] 		Tap, William
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Elacytarabine versus Investigator's Choice in Patients with Late-Stage Acute Myeloid Leukemia
[Protocol 10-113] 		Douer, Dan
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase III Study of Etoposide/Platinum with and without Ipilimumab in Patients with Newly Diagnosed Advanced Small Cell Lung Cancer
[Protocol 12-202] 		Pietanza, M. Catherine
  • Lung Cancer
  • Lung Cancer, Small Cell
A Phase III Study of Everolimus versus Placebo in Patients with Neuroendocrine Tumors Originating in the Lungs or Gastrointestinal Tract: The RADIANT-4 Study
[Protocol 12-250] 		Reidy-Lagunes, Diane
  • Lung Cancer
  • Upper Gastrointestinal
    • Neuroendocrine
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119] 		Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase III Study of Gemcitabine, Docetaxel, and Doxorubicin versus Observation in Women with High-Grade Uterine Leiomyosarcoma
[Protocol 12-177] 		Hensley, Martee
  • Endometrial and other Uterine Cancers
    • Leiomyosarcoma
    • Uterine Cancer
  • Leiomyosarcoma
  • Sarcomas
    • Leiomyosarcoma
    • Soft Tissue Sarcoma
A Phase III Study of Hormone Therapy with and without Chemotherapy in Patients with HER2-Negative Breast Cancer and 1-3 Positive Lymph Nodes and a Recurrence Score of 25 or Less
[Protocol 12-118] 		Lake, Diana
  • Breast Cancer
A Phase III Study of Ibritumomab Tiuxetan versus Observation in Older Patients with Diffuse Large B-Cell Lymphoma in Remission following R-CHOP
[Protocol 12-061] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Inotuzumab Ozogamicin with Rituximab versus Standard Therapy for Patients with Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
[Protocol 12-005] 		Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of KW-0761 versus Vorinostat in Patients with Previously Treated Cutaneous T-Cell Lymphoma
[Protocol 13-007] 		Moskowitz, Alison
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128] 		Klimek, Virginia
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Myelodysplastic Syndrome
A Phase III Study of Lenalidomide, Bortezomib, and Dexamethasone Combination Treatment with or without Peripheral Stem Cell Transplantation in the Initial Management of Multiple Myeloma
[Protocol 12-018] 		Hassoun, Hani
  • Hematology
    • Multiple Myeloma
A Phase III Study of Multimodality Therapy for Extra-ocular Retinoblastoma
[Protocol 08-072] 		Dunkel, Ira
  • Retinoblastoma
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041] 		Eastham, James
  • Prostate Cancer
    • Localized Disease
A Phase III Study of Nilotinib (Tasigna®) versus Dacarbazine in Patients with Advanced Melanoma with a c-Kit Mutation (TEAM Trial
[Protocol 10-102] 		Carvajal, Richard
  • Melanoma
A Phase III Study of Ofatumumab versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
[Protocol 11-079] 		Matasar, Matthew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Paclitaxel plus Carboplatin Versus Ifosfamide plus Paclitaxel in Chemotherapy-Naive Patients with Newly Diagnosed Persistent or Recurrent Carcinosarcoma of the Uterus
[Protocol 10-007] 		Hensley, Martee
  • Endometrial and other Uterine Cancers
    • Uterine Cancer
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase III Study of Pazopanib as Adjuvant Therapy for Patients with Localized or Locally Advanced Renal Cell Carcinoma Following Nephrectomy
[Protocol 10-162] 		Motzer, Robert
  • Kidney Cancer
A Phase III Study of Ponatinib versus Imatinib for Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
[Protocol 12-216] 		Berman, Ellin
  • Leukemia
    • Chronic Myelocytic Leukemia
A Phase III Study of Postoperative Radiation Therapy with and without Cetuximab for Locally Advanced Resected Head and Neck Cancer
[Protocol 10-081] 		Lee, Nancy
  • Head & Neck Cancer
On Our Blog